Atopic eczema treatment now and in the future: Targeting the skin barrier and key immune mechanisms in human skin

doi:10.5314/wjd.v6.i3.42

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (26921)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

1267

WORD

426

HTML

19180

Figures (1-4)

442

Tables (1-1)

241

Sum=21556

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1558

Download

1662

Sum=3220

Publishing Process of This Article

Item

Count

Browse

1007

Download

1138

Sum=2145

Aug 2, 2017 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Dermatology

ISSN

2218-6190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Dermatol. Aug 2, 2017; 6(3): 42-51
Published online Aug 2, 2017. doi: 10.5314/wjd.v6.i3.42

Table 1 Novel therapeutic strategies targeting atopic eczema

Repairing the damaged skin barrier	Reducing atopic inflammation
XPL (second skin)	Crisaborole
Emollients with increased ceramide NP levels	Dupilumab
Vitamin D (calcitriol)	hβD-2

Novel therapeutic strategies and mechanisms of action in atopic eczema.XPL: Cross-linked polymer; hβD-2: Human beta defensin 2.

Citation: Bell DC, Brown SJ. Atopic eczema treatment now and in the future: Targeting the skin barrier and key immune mechanisms in human skin. World J Dermatol 2017; 6(3): 42-51
URL: https://www.wjgnet.com/2218-6190/full/v6/i3/42.htm
DOI: https://dx.doi.org/10.5314/wjd.v6.i3.42